Should the fallopian tubes be removed (salpingectomy) during a hysterectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Should Fallopian Tubes Be Removed During Hysterectomy?

Yes, opportunistic salpingectomy should be performed at the time of hysterectomy for benign indications to reduce the risk of ovarian cancer, as this is safe, does not increase complications, and provides meaningful cancer prevention benefits. 1

Rationale for Routine Salpingectomy

The recommendation for opportunistic salpingectomy is based on the understanding that many high-grade serous ovarian cancers originate in the fallopian tubes rather than the ovaries themselves. By removing the tubes during hysterectomy (when they would otherwise serve no further function), you can reduce ovarian cancer risk without the need for oophorectomy and its associated consequences of surgical menopause.

Key benefits include:

  • Reduces ovarian cancer risk by preventing 1 cancer diagnosis per 225 women and 1 cancer death per 450 women undergoing surgery 2
  • Does not increase major complication rates meaningfully (7.95% vs 7.68% for hysterectomy alone) 2
  • Does not affect ovarian function based on serum markers 1
  • Actually reduces overall costs due to decreased need for future adnexal surgery 2
  • Safe across all surgical approaches (abdominal, laparoscopic, robotic) 1

Surgical Approach Considerations

For vaginal hysterectomy specifically: Salpingectomy is feasible in approximately 81% of cases when attempted 3. It adds only 11 minutes to operative time and 6 mL of additional blood loss 3. However, completion rates are lower via the vaginal route (13%) compared to laparoscopic (70%), robotic (73%), or open approaches (65%) 4.

Factors that may limit vaginal salpingectomy:

  • Prior adnexal surgery (odds ratio 2.9)
  • Uterine fibroids (odds ratio 5.8)
  • Tubes positioned high in the pelvis
  • Bowel or sidewall adhesions 3

Important caveat: The planned route of hysterectomy should NOT be altered to accommodate salpingectomy. Continue using minimally invasive techniques as clinically appropriate 1.

Special Populations

For women with hereditary cancer syndromes (BRCA1/2, Lynch syndrome, etc.): The guidelines differ significantly. These patients require risk-reducing bilateral salpingo-oophorectomy (RRBSO), not just salpingectomy, as they face substantially elevated ovarian cancer risk (44% for BRCA1, 17% for BRCA2) 5. Hysterectomy is not routinely recommended at the time of RRBSO unless there are additional indications such as Lynch syndrome genes (MLH1, MSH2, MSH6) or other risk factors for endometrial cancer 5.

Informed Consent Discussion

When counseling patients, explicitly discuss:

  • What salpingectomy does: Reduces but does not eliminate ovarian cancer risk
  • What it doesn't do: Does not provide the same protection as bilateral salpingo-oophorectomy
  • Safety profile: Minimal increase in complications (approximately 0.61 additional complications per cancer prevented) 2
  • Ovarian function: Preserved after salpingectomy alone
  • Alternative of oophorectomy: Should be mentioned but generally avoided in premenopausal women due to increased risks of cardiovascular disease, osteoporosis, cognitive impairment, and all-cause mortality 1

Clinical Algorithm

For average-risk women undergoing hysterectomy for benign indications:

  1. Offer opportunistic bilateral salpingectomy as standard practice
  2. Proceed with salpingectomy via the planned surgical route
  3. If vaginal approach and tubes cannot be safely accessed, do not convert to another route solely for tube removal
  4. Document discussion and decision in operative consent

For high-risk women (genetic mutations):

  1. Refer to genetics/high-risk clinic for comprehensive evaluation
  2. Consider RRBSO at appropriate age based on specific mutation
  3. Add hysterectomy only if Lynch syndrome or other endometrial cancer risk factors present 5, 6

The evidence strongly supports routine opportunistic salpingectomy as a cancer prevention strategy that is both safe and cost-effective, with the trade-off between minimal additional complications and meaningful cancer prevention being highly favorable 1, 2.

Related Questions

Is a morning blood pressure of 105/54 mm Hg normal, and what management is recommended if the patient is asymptomatic?
How should I manage a 10-month-old infant with a rectal temperature of 100.6 °F and two episodes of vomiting?
What is the appropriate management for a 10‑month‑old infant with cough, wheezing, coarse breath sounds, and diarrhea?
What is the recommended evaluation and management for a 10-year-old male with pubic pain, intermittent dysuria for 2–3 months, decreased appetite, and urine specific gravity of 1.015?
What is the appropriate evaluation and management for a patient with a 0.5 cm round ground‑glass opacity in the right upper lung who has been exposed to chemicals and now presents with a chronic cough?
What is the significance of blooming artifact on magnetic resonance imaging (MRI)?
What are alternative medications to naltrexone for treating opioid use disorder and alcohol use disorder?
For a 78‑kg adult with type 1 diabetes on dexamethasone 2 mg, currently using insulin glargine (Lantus) 20 U, NPH (neutral protamine Hagedorn) insulin 100 U at 6 pm, insulin‑to‑carbohydrate ratio 1 U per 10 g carbohydrate, daytime insulin sensitivity factor 50 mg/dL per unit, and nighttime insulin sensitivity factor 15 mg/dL per unit, and given the reported glucose readings, what should the insulin‑to‑carbohydrate ratio, glargine dose, and NPH dose be adjusted to?
What other causes can explain a sensation of fullness or swelling in the pelvic region?
What antibiotic regimen is recommended for a patient with bacterial sinusitis who is allergic to ciprofloxacin, cefdinir, sulfonamides, penicillins, azithromycin (Zithromax), nitrofurantoin (Macrobid), and amoxicillin?
How should a serum potassium of 5.0 mEq/L be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.